CSIR Center for Cellular and Molecular Biology

07 May 2021 Current Affairs:The CSIR Center for Cellular and Molecular Biology has developed and may be the first specific drug for the treatment of COVID-19, which contains therapeutic antibodies.

Highlights:
♦ The Drug Controller General of India (DGCI) has approved clinical trials for the VINCOV-19 in Phases I and II, and it is expected to be tested in Delhi and Rajasthan soon.
♦ The VINCOV-19 is a series of antibodies collected from horses after they were given inactivated Corona virus injections.
♦ After the results of phase I and II are released, it is expected to be approved for emergency use.
♦ It works better when given early in the infection.
 

Leave a Reply

Your email address will not be published. Required fields are marked *